Becton, Dickinson and Company (NYSE:BDX) was among the stocks on which Jim Cramer gave his opinion, as he warned that increased AI-related spending might cause near-term headwind for stocks. When a caller mentioned that they had started a position in the stock, Cramer commented:
I like Becton, Dickinson. It is selling frankly at the lowest level to the market that I have ever seen. I think you buy some and then you wait to see if they even oversell it more. That stock is very inexpensive.
Stock market data. Photo by Photo by Alesia Kozik
Becton, Dickinson and Company (NYSE:BDX) sells a variety of medical supplies, diagnostic tools, and lab equipment used by healthcare professionals and researchers. Cramer highlighted the company’s recent earnings during the May 7 episode, as he said:
This morning, we got a strong quarter from Becton, Dickinson and Company, which is one of the major medical supply and medical technology companies. After spending the last five years with some fine growth, Becton, Dickinson really shot the lights out with this one. Huge top and bottom line beat, management raising the full year earnings forecast, and that sent the stock up nearly 6% today on a not-so-great day for the market. The company showed excellent execution across the board. They’re getting a real boost from all sorts of technology that helps hospitals do more with fewer people.
While we acknowledge the potential of BDX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years
Disclosure: None. Follow Insider Monkey on Google News.
